Stable Isotope Labeled Ustekinumab Biosimilar – Anti-Human IL-12 IL-23 mAb – Research Grade
Size | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Stable Isotope Labeled Ustekinumab Biosimilar - Anti-Human IL-12 IL-23 mAb - Research Grade |
---|---|
Source | DrugBank DB05679 |
Species | Human |
Expression system | Mammalian cells |
Molecular weight | 148kDa |
Purity | >90% |
Buffer | PBS pH7.5 |
Delivery condition | Blue Ice |
Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
Storage condition | 4°C for short term; -20°C for long term |
Brand | ProteoGenix |
Aliases /Synonyms | Ustekinumab |
Reference | PX-TA1011-SIL |
Related Products | PX-P4570,PX-P5123 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG1 |
Clonality | Monoclonal Antibody |
Format | Lyophilized |
Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2 |
Isotopic Enrichment | 99% |
Stability | 1 year |
General information about Ustekinumab
Ustekinumab is a human monoclonal antibody used to treat psoriasis. It is also approved to treat Crohn’s disease and ulcerative colitis among people who have not responded to more traditional treatments. It is a subcutaneous human interleukin 12 and interleukin 23 antagonist. These are naturally occurring proteins that regulate the immune system and immune-mediated inflammatory disorders. This product is for research use only.
Related products
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.